Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Cash (2016 - 2025)

Historic Change in Cash for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $1.9 million.

  • Conmed's Change in Cash rose 11347.8% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $16.4 million, marking a year-over-year increase of 993558.28%. This contributed to the annual value of $16.4 million for FY2025, which is 993558.28% up from last year.
  • Conmed's Change in Cash amounted to $1.9 million in Q4 2025, which was up 11347.8% from $5.0 million recorded in Q3 2025.
  • Over the past 5 years, Conmed's Change in Cash peaked at $28.3 million during Q2 2022, and registered a low of -$19.8 million during Q3 2022.
  • For the 5-year period, Conmed's Change in Cash averaged around $673050.0, with its median value being $1.6 million (2023).
  • Over the last 5 years, Conmed's Change in Cash had its largest YoY gain of 70846.8% in 2021, and its largest YoY loss of 251902.44% in 2021.
  • Quarter analysis of 5 years shows Conmed's Change in Cash stood at -$10.7 million in 2021, then skyrocketed by 58.63% to -$4.4 million in 2022, then crashed by 40.66% to -$6.2 million in 2023, then crashed by 125.72% to -$14.0 million in 2024, then soared by 113.48% to $1.9 million in 2025.
  • Its Change in Cash stands at $1.9 million for Q4 2025, versus $5.0 million for Q3 2025 and -$1.5 million for Q2 2025.